Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-04-29
(1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2024-04-23
VOLUNTARY ANNOUNCEMENT – UPDATES ON RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 AACR ANNUAL MEETING 2024-04-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 2024-04-03
(1) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION; AND (2) RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT 2024-04-02
CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT 2024-03-28
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 2024-03-28
DATE OF BOARD MEETING 2024-03-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 2024-03-05
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications 2024-02-06